Trial of Rosuvastatin for the Prevention of Kidney Toxicity caused by Tobramycin in Children with Cystic Fibrosis Trial of Rosuvastatinfor the Prevention of Kidney Toxicity caused by Tobramycin in Children with Cys ...
Phase IIa, Randomised, Controlled, Open-Label Trial of Rosuvastatin for the Prevention of Aminoglycoside-Induced Kidney Toxicity in Children with Cystic Fibrosis - PROteKT Phase IIa, Randomised, Controlled, Open-Label Trial of Rosuvastatinfor the Prevention of Aminoglycos ...